Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although a number of studies have suggested that the use of Telemonitoring (TM) in patients with Chronic Obstructive Pulmonary Disease (COPD) can be useful and efficacious, its real utility in detecting Acute Exacerbation (AE) signaling the need for prompt treatment is not entirely clear. The current study aimed to investigate the benefits of a TM system in managing AE in advanced-stage COPD patients to improve their Health-Related Quality of Life (HRQL) and to reduce utilization of healthcare services. METHODS: A 12-month Randomised Controlled Trial (RCT) was conducted in the Veneto region (Italy). Adult patients diagnosed with Class III-IV COPD in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification were recruited and provided a TM system to alert the clinical staff via a trained operator whenever variations in respiratory parameters fell beyond the individual's normal range. The study's primary endpoint was HRQL, measured by the Italian version of the two Short Form 36-item Health Survey (SF36v2). Its secondary endpoints were: scores on the Hospital Anxiety and Depression Scale (HADS); the number and duration of hospitalizations; the number of readmissions; the number of appointments with a pulmonary specialist; the number of visits to the emergency department; and the number of deaths. RESULTS: Three hundred thirty-four patients were enrolled and randomized into two groups for a 1 year period. At its conclusion, changes in the SF36 Physical and Mental Component Summary scores did not significantly differ between the TM and control groups [(-2.07 (8.98) vs -1.91 (7.75); p = 0.889 and -1.08 (11.30) vs -1.92 (10.92); p = 0.5754, respectively]. Variations in HADS were not significantly different between the two groups [0.85 (3.68) vs 0.62 (3.6); p = 0.65 and 0.50 (4.3) vs 0.72 (4.5); p = 0.71]. The hospitalization rate for AECOPD and/or for any cause was not significantly different in the two groups [IRR = 0.89 (95% CI 0.79-1,04); p = 0.16 and IRR = 0.91 (95% CI 0,75 - 1.04); p = 0.16, respectively]. The readmission rate for AECOPD and/or any cause was, however, significantly lower in the TM group with respect to the control one [IRR = 0.43 (95% CI 0.19-0.98); p = 0.01 and 0.46 (95% CI 0.24-0.89); p = 0.01, respectively]. CONCLUSION: Study results showed that in areas where medical services are well established, TM does not significantly improve HRQL in patients with COPD who develop AE. Although not effective in reducing hospitalizations, TM can nevertheless facilitate continuity of care during hospital-to-home transition by reducing the need for early readmission. TRIAL REGISTRATION: Retrospectively registered on January 2012, ClinicalTrials.gov Identifier: NCT01513980 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0803563 · Cited by 5,164
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927 · cited 1×
“The data collected at baseline included the following: demographic, smoking status, level of education, marital and employment status; the modified Medical Research Council (mMRC) dyspnoea score [17]; the COPD Assessment Test (CAT) score [18]; scores on the Hospital Anxiety and Depression Scale (HADS).”
MethodCharacterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 1×
“COPD has, in fact, shown high clinical and functional intraindividual variability [36] which may reduce the ability of one-dimensional models to recognize a wide range of events (i.”
BackgroundPinnock, H., Hanley, J., McCloughan, L., Todd, A., Krishan, A., Lewis, S., Stoddart, A., van der Pol, M., MacNee, W., Sheikh, A., et al. (2013) · BMJ · doi:10.1136/bmj.f6070 · Cited by 310
Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis
Polisena, J., Tran, K., Cimon, K., Hutton, B., McGill, S., Palmer, K., & Scott, R. E. (2010) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2009.090812 · Cited by 300 · cited 1×
“, in fact, concluded that TM does not improve HRQL when it is compared to usual care [11].”
BackgroundTelehealthcare for chronic obstructive pulmonary disease
McLean, S., Nurmatov, U., Liu, J. L., Pagliari, C., Car, J., & Sheikh, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007718.pub2 · Cited by 225
Bolton, C. E., Waters, C. S., Peirce, S., & Elwyn, G. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01536.x · Cited by 140
Bartoli, L., Zanaboni, P., Masella, C., & Ursini, N. (2009) · Telemedicine and e-Health · doi:10.1089/tmj.2009.0044 · Cited by 85
Cited by
Lenferink, A., Brusse-Keizer, M., van der Valk, P. D., Frith, P. A., Zwerink, M., Monninkhof, E. M., van der Palen, J., & Effing, T. W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011682.pub2 · Cited by 328
How will telemedicine change clinical practice in chronic obstructive pulmonary disease?
Vitacca, M., Montini, A., & Comini, L. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465818754778 · Cited by 101
Hong, Y., & Lee, S. H. (2019) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2018.12.006 · Cited by 73
Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., Wright, D. J., Lane, D. A., & the TAILOR investigators (2022) · Journal of Medical Internet Research · doi:10.2196/35508 · Cited by 62
“…1.9.2: Minnesota Living with Heart Failure Questionnaire (MLHFQ); 1.9.3: SF-36 mental score; and 1.9.4: SF-36 physical component [15,31,35,47,96,101,104,136]. al [80] was not included in the mortality meta-analyses because of the use of a composite outcome of mortality and hospitalization where…”
InfluentialGrosman-Rimon, L., & Wegier, P. (2024) · Medicine · doi:10.1097/md.0000000000039136 · Cited by 46
Metadata
- Authors
- Vianello, A., Fusello, M., Gubian, L., Rinaldo, C., Dario, C., Concas, A., Saccavini, C., Battistella, L., Pellizzon, G., Zanardi, G., & Mancin, S.
- Venue
- BMC Pulmonary Medicine
- Published
- 2016-11-22
- Volume
- 16
- Issue
- 1
- Pages
- 157-157
- ISSN
- 1471-2466 (ISSN-L)
- OpenAlex
- W2554776199
- Cited by
- 84
- References
- 9
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12890-016-0321-2
- The paper
- Vianello, A., Fusello, M., Gubian, L., Rinaldo, C., Dario, C., Concas, A., Saccavini, C., Battistella, L., Pellizzon, G., Zanardi, G., & Mancin, S. (2016). Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-016-0321-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.